2-168973818-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003742.4(ABCB11):​c.1331T>C​(p.Val444Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.591 in 1,610,750 control chromosomes in the GnomAD database, including 282,763 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 25038 hom., cov: 30)
Exomes 𝑓: 0.59 ( 257725 hom. )

Consequence

ABCB11
NM_003742.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.39

Publications

164 publications found
Variant links:
Genes affected
ABCB11 (HGNC:42): (ATP binding cassette subfamily B member 11) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008]
ABCB11 Gene-Disease associations (from GenCC):
  • progressive familial intrahepatic cholestasis type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • benign recurrent intrahepatic cholestasis type 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.0099598E-5).
BP6
Variant 2-168973818-A-G is Benign according to our data. Variant chr2-168973818-A-G is described in ClinVar as Benign. ClinVar VariationId is 194214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.697 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCB11NM_003742.4 linkc.1331T>C p.Val444Ala missense_variant Exon 13 of 28 ENST00000650372.1 NP_003733.2 O95342

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCB11ENST00000650372.1 linkc.1331T>C p.Val444Ala missense_variant Exon 13 of 28 NM_003742.4 ENSP00000497931.1 O95342

Frequencies

GnomAD3 genomes
AF:
0.572
AC:
86689
AN:
151500
Hom.:
25023
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.567
Gnomad AMI
AF:
0.660
Gnomad AMR
AF:
0.463
Gnomad ASJ
AF:
0.575
Gnomad EAS
AF:
0.717
Gnomad SAS
AF:
0.567
Gnomad FIN
AF:
0.511
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.580
GnomAD2 exomes
AF:
0.569
AC:
141494
AN:
248542
AF XY:
0.574
show subpopulations
Gnomad AFR exome
AF:
0.571
Gnomad AMR exome
AF:
0.423
Gnomad ASJ exome
AF:
0.558
Gnomad EAS exome
AF:
0.728
Gnomad FIN exome
AF:
0.515
Gnomad NFE exome
AF:
0.599
Gnomad OTH exome
AF:
0.564
GnomAD4 exome
AF:
0.593
AC:
864780
AN:
1459132
Hom.:
257725
Cov.:
40
AF XY:
0.592
AC XY:
429695
AN XY:
725906
show subpopulations
African (AFR)
AF:
0.578
AC:
19267
AN:
33362
American (AMR)
AF:
0.424
AC:
18935
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.563
AC:
14663
AN:
26024
East Asian (EAS)
AF:
0.728
AC:
28857
AN:
39646
South Asian (SAS)
AF:
0.569
AC:
49040
AN:
86182
European-Finnish (FIN)
AF:
0.512
AC:
27330
AN:
53360
Middle Eastern (MID)
AF:
0.584
AC:
3356
AN:
5746
European-Non Finnish (NFE)
AF:
0.602
AC:
667981
AN:
1109968
Other (OTH)
AF:
0.587
AC:
35351
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
17135
34270
51406
68541
85676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18198
36396
54594
72792
90990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.572
AC:
86740
AN:
151618
Hom.:
25038
Cov.:
30
AF XY:
0.566
AC XY:
41919
AN XY:
74026
show subpopulations
African (AFR)
AF:
0.567
AC:
23421
AN:
41320
American (AMR)
AF:
0.463
AC:
7017
AN:
15168
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
1997
AN:
3472
East Asian (EAS)
AF:
0.716
AC:
3672
AN:
5126
South Asian (SAS)
AF:
0.568
AC:
2733
AN:
4812
European-Finnish (FIN)
AF:
0.511
AC:
5386
AN:
10532
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.597
AC:
40528
AN:
67890
Other (OTH)
AF:
0.583
AC:
1222
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1911
3822
5734
7645
9556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
748
1496
2244
2992
3740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.587
Hom.:
79180
Bravo
AF:
0.571
TwinsUK
AF:
0.602
AC:
2231
ALSPAC
AF:
0.611
AC:
2354
ESP6500AA
AF:
0.586
AC:
2194
ESP6500EA
AF:
0.600
AC:
4941
ExAC
AF:
0.579
AC:
69942
Asia WGS
AF:
0.659
AC:
2292
AN:
3476
EpiCase
AF:
0.608
EpiControl
AF:
0.611

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 14, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Progressive familial intrahepatic cholestasis type 2 Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Benign recurrent intrahepatic cholestasis type 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Benign recurrent intrahepatic cholestasis type 2;C3489789:Progressive familial intrahepatic cholestasis type 2 Benign:1
Jun 28, 2025
Immunogenetics and Transplant Biology Service, University Hospital "Città della Salute e della Scienza di Torino"
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.27
T;T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.71
.;T
MetaRNN
Benign
0.000020
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.14
N;N
PhyloP100
2.4
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.010
N;.
REVEL
Benign
0.26
Sift
Benign
0.25
T;.
Sift4G
Benign
0.59
T;.
Polyphen
0.0010
B;B
Vest4
0.055
MPC
0.17
ClinPred
0.013
T
GERP RS
4.6
Varity_R
0.10
gMVP
0.68
Mutation Taster
=53/47
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2287622; hg19: chr2-169830328; COSMIC: COSV55585312; COSMIC: COSV55585312; API